ARCHIVES

ODAC Recommends Fludarabine Approval for Refractory CLL

This article is from The Cancer Letter archive.

Vol. 16 No. 36 | September 21, 1990

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 10 Issue 1, Spring 1996

April 13, 1996

NCI to Implement More Transparent Formula For Calculating Cancer Center Support Grants

July 11, 2014

“Mini-Transplantation” In Testing For Treatment Of Multiple Myeloma

January 25, 2002

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009

In Brief: NCI Needs To Move Quicker On Funding Jot New Leads, Rauscher Says; Harley Dirks Quits

October 15, 1976

RFA On Promoters, Hormones, Other Cofactors Available

July 17, 1981